Visual and somatosensory evoked potentials in Parkinson's and Binswanger's disease

被引:6
|
作者
Okuda, B
Tachibana, H
Takeda, M
Kawabata, K
Sugita, M
机构
[1] Fifth Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya
来源
DEMENTIA | 1996年 / 7卷 / 01期
关键词
Parkinson's disease; Binswanger's disease; VEP; SEP; dementia;
D O I
10.1159/000106853
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To compare subcortical involvement of Parkinson's disease (PD) with that of Binswanger's disease (ED), we examined visual evoked potentials (VEPs) and somatosensory evoked potentials (SEPs) in 29 patients with PD and 7 patients with ED and 11 control subjects. The patients with PD were divided into two groups: PD without dementia (nD-PD: n = 18) and PD with dementia (D-PD: n = 11). The D-PD patients showed significantly longer P100 latencies in VEPs compared with the nD-PD patients or controls. The P100 latencies were negatively correlated with Mini-Mental State Examination (MMSE) score in the PD patients. The ED patients showed significantly longer central conduction time (CCT) in SEPs (interpeak latency between N13 and N20 responses) compared with the nD-PD patients or controls. There was no correlation between CCT and MMSE score in the ED patients. These results suggest that PD has a predilection for sensory system involvement distinct from that of ED. In D-PD, the visual system seems more vulnerable than the somatosensory system, but almost the reverse is true of ED.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 50 条
  • [12] Abnormality of N30 somatosensory evoked potentials in Parkinson's disease: a multidisciplinary approach
    Bostantjopoulou, S
    Katsarou, Z
    Zafiriou, D
    Gerasimou, G
    Alevriadou, A
    Georgiadis, G
    Kiosseoglou, G
    Kazis, A
    NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2000, 30 (06): : 368 - 376
  • [13] Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease
    Trenado, Carlos
    Elben, Saskia
    Friggemann, Lena
    Gruhn, Sonja
    Groiss, Stefan Jun
    Vesper, Jan
    Schnitzler, Alfons
    Wojtecki, Lars
    PLOS ONE, 2017, 12 (01):
  • [14] Somatosensory evoked potentials correlate with genetics in Huntington's disease
    Beniczky, S
    Kéri, S
    Antal, A
    Jakab, K
    Nagy, H
    Benedek, G
    Janka, Z
    Vécsei, L
    NEUROREPORT, 2002, 13 (17) : 2295 - 2298
  • [15] Somatosensory Evoked Potentials and pain assessment in Alzheimer's disease
    Limongi, F.
    Radaelli, S.
    Noale, M.
    Maggi, S.
    Crepaldi, G.
    EUROPEAN GERIATRIC MEDICINE, 2013, 4 (06) : 384 - 388
  • [16] Short latency somatosensory evoked potentials and symptomatic response to dopaminergic medications in patients with Parkinson's disease
    Castillo, JL
    Miranda, M
    Araya, F
    Saez, D
    REVISTA MEDICA DE CHILE, 1996, 124 (03) : 301 - 306
  • [17] Amantadine sulfate infusion effect on N30 somatosensory evoked potentials in Parkinson's disease
    Bostantjopoulou, S
    Katsarou, Z
    Georgiadis, G
    Zafiriou, D
    Kazis, A
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (02) : 115 - 118
  • [18] Effects of Dopaminergic Treatment on Contrast Sensitivity, Visual Evoked Potentials and Visual Field in the Parkinson's Disease
    Ture, Sabiha
    Inci, Ipek
    Gedizlioglu, Muhtesem
    Ture, Melih
    TURKISH JOURNAL OF NEUROLOGY, 2007, 13 (02) : 81 - 87
  • [19] Simultaneously evoked primary and cognitive visual evoked potentials distinguish younger and older patients with Parkinson's disease
    Antal, A
    Pfeiffer, R
    BodisWollner, I
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (8-9) : 1053 - 1067
  • [20] Somatosensory-evoked potentials in vascular dementia and in Alzheimer's disease
    Paradowski, Boguslaw
    Kusinska, Elzbieta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2007, 16 (02): : 263 - 267